Sunday - October 4, 2026
Dana-Farber Research Reveals Possible New Target for Treatment of Sickle Cell and Beta Thalassemia
September 30, 2026
BOSTON, Massachusetts, Sept. 30 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Dana-Farber Research Reveals Possible New Target for Treatment of Sickle Cell and Beta Thalassemia

*

Research Summary

Study Title: Human genetics implicates a BACH2-NRF2 axis in fetal hemoglobin 1 activation

Publication: Nature

Dana-Farber Cancer Institute corresponding au . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products